We came across a bullish thesis on Evolus, Inc. (EOLS) on Substack by Greg ┃The Elevator Pitch. In this article, we will summarize the bulls’ thesis on EOLS. Evolus, Inc. (EOLS)’s share was trading at $11.76 as of May 7th. EOLS’s forward P/E was 117.65 according to Yahoo Finance.
ATeam/Shutterstock.com
Evolus has quickly positioned itself as a disruptive force in the global injectable aesthetics market, traditionally dominated by pharmaceutical giants like AbbVie and Galderma. The...
